VRX-RET-E22-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VRX-RET-E22-301, covering 2016-11-25 to 2016-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial [Phase 3]